Vertex non-opioid pain drug succeeds in late-stage trials

(Reuters) – Vertex Pharmaceuticals said on Tuesday its experimental drug for treating post-surgical pain succeeded in a pair of late-stage trials, a major milestone in the company’s decades-long efforts to bring a non-opioid pain medicine to market.

(Reporting by Leroy Leo and Sriparna Roy in Bengaluru; Editing by Sriraj Kalluvila and Bill Berkrot)